Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. 1996

U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
Department of Medical Microbiology, Hannover Medical School, Germany.

The human C5a receptor (C5aR) belongs to the family of G-protein-coupled receptors with seven transmembrane helices. This part of the molecule is thought to contain part of the ligand-binding pocket, specifically to bind the C-terminal Arg of human C5a. Guided by sequence similarity and molecular modelling studies, several residues including polar (Asn119, Thr168, Gln259) as well as all conserved charged amino acids in the upper transmembrane region of the C5aR (Asp37, Asp82, Arg175, Arg2O6, Asp282) were exchanged by site-directed mutagenesis. Receptor mutants were transiently expressed in COS cells and analyzed for altered binding behaviour and/or localization at the cell surface by immunofluorescence. For all residues, suitable mutants could be found that exhibited wild-type affinity towards the ligand, providing evidence against a major contribution of these residues to high-affinity ligand binding. Some mutants, however, exhibited a complete (Asp282-->Ala) or partial loss of ligand-binding capacity (Arg175-->Ala, Arg2O6-->Gln) despite adequate expression levels on the cell surface. This phenotype was further analyzed in the [Gln2O6]C5aR mutant: quantitative flow cytometric analysis of epitope-tagged receptor derivatives in 293 cells confirmed an equal level of wild-type and mutant C5aR on the cell surface. Competitive binding curves revealed the presence of only a small population (<10%) of high-affinity sites (Kd approximately 2 nM), which was functionally active at 20 nM in the heterologous Xenopus oocyte expression system after coexpression of G alpha-16. The number of high-affinity sites of wild-type and [Gln2O6]C5aR in 293 cells could be up-regulated by coexpression of Gi alpha-2 and down-regulated by GTP[gamma S]-mediated uncoupling of the G-protein receptor interaction in membrane preparations. These findings are compatible with a model in which the Arg2O6 residue located in the upper third of transmembrane helix V determines high-affinity binding in the human C5aR by affecting the intracellular G-protein coupling.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011951 Receptors, Complement Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement Receptors,Complement Receptor,Complement Receptor Type 1,Receptor, Complement
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
January 1989, Proceedings of the National Academy of Sciences of the United States of America,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
September 2002, Biochemistry,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
February 1995, Biochemical Society transactions,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
December 1994, Archives of biochemistry and biophysics,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
May 1998, Molecular pharmacology,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
October 1994, Glycoconjugate journal,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
January 2007, Biochemical and biophysical research communications,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
September 1999, European journal of pharmacology,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
February 1994, European journal of biochemistry,
U Raffetseder, and D Röper, and L Mery, and C Gietz, and A Klos, and J Grötzinger, and A Wollmer, and F Boulay, and J Köhl, and W Bautsch
December 1992, Biochemical and biophysical research communications,
Copied contents to your clipboard!